Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The firm operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Follow-Up Questions
Who is the CEO of Amarin Corporation PLC?
Mr. Aaron Berg is the President of Amarin Corporation PLC, joining the firm since 2014.
What is the price performance of AMRN stock?
The current price of AMRN is $14.96, it has increased 0.26% in the last trading day.
What are the primary business themes or industries for Amarin Corporation PLC?
Amarin Corporation PLC belongs to Biotechnology industry and the sector is Health Care
What is Amarin Corporation PLC market cap?
Amarin Corporation PLC's current market cap is $309.4M
Is Amarin Corporation PLC a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for Amarin Corporation PLC, including 0 strong buy, 0 buy, 3 hold, 3 sell, and 0 strong sell
